AppremedCOV50 test
18 May 2021
APPREMED supports the COV50 test for the early risk stratification and the timely administration of monoclonal antibodies.
A copy of the support letter can be found at the submenu 'COVID-19' in the 'Publications' tab.
18 May 2021
APPREMED supports the COV50 test for the early risk stratification and the timely administration of monoclonal antibodies.
A copy of the support letter can be found at the submenu 'COVID-19' in the 'Publications' tab.